| Literature DB >> 24016271 |
Dominik D Alexander1, William H Bailey, Vanessa Perez, Meghan E Mitchell, Steave Su.
Abstract
BACKGROUND: From a mechanistic or physical perspective there is no basis to suspect that electric charges on clusters of air molecules (air ions) would have beneficial or deleterious effects on respiratory function. Yet, there is a large lay and scientific literature spanning 80 years that asserts exposure to air ions affects the respiratory system and has other biological effects. AIMS: This review evaluates the scientific evidence in published human experimental studies regarding the effects of exposure to air ions on respiratory performance and symptoms.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24016271 PMCID: PMC3848581 DOI: 10.1186/1477-5751-12-14
Source DB: PubMed Journal: J Negat Results Biomed ISSN: 1477-5751
Descriptive characteristics of experimental studies on air ions and respiratory outcome measures
| | | | | | |
| [ | Measure effects of ion exposure to bronchial asthma subjects and comparison to conventional treatment. | Double-blind | Infant patients aged 2–12 months with bronchial asthma. | 19 (13 with bronchial asthma and 6 without asthma); 19 additional subjects at different hospital with same diagnosis. | Respiratory rate and scored degree of bronchospasm severity. |
| | | | | ||
| [ | Measure therapeutic effect of negative air ions on exercise-or inhaled histamine-induced asthma. | Double-blind randomized | Asthmatic children aged 10–20 yrs recruited from patient population. | 11 (for exercise challenge); 9 (for histamine challenge) | FEV1 |
| [ | Measure efficacy of negative ion treatment for asthma patients. | Double-blind | Asthmatic male students aged 8.8 to 12.6 years at a special school for asthmatics | 24 | Lung function (whole-body plethysmorgraph and nitrogen washout) |
| [ | Measure respiratory effects of positive ions on asthmatic children under physical exertion; follow-up study from [ | Double-blind randomized | Asthmatic children aged 9–15 yrs recruited from patient population. | 12; 7 M and 5 F | Lung function (FEV1 and minute ventilation), oxygen consumption, heart rate, and respiratory heat loss. |
| [ | Measure effects of air ions on concentration of airborne dust mite allergen in air and asthmatics | Double-blind crossover | Asthmatic children aged 3–11 yrs recruited from clinic's patient population who's home environments have elevated dust mite allergen air concentration. | 20 | Peak expiratory flow rate (PEFR) morning and night; self-reported symptom scores; self-medication scores; air concentration of |
| | | | | ||
| [ | Measure efficacy of negative ion treatment for asthma patients. | Subject-blind | Asthma patients aged 10–54 yrs; Male=6, Female=1. | 7 | Peak expiratory flow rate (PEFR); self-reported symptoms. |
| [ | Measure efficacy of negative ion treatment for patients suffering from respiratory symptoms | N.S. | Patients male and female aged 7 to 59 years | 27 | Relief from hay fever, bronchial asthma, neurogenic asthma, acute rhinitis, allergic rhinitis, subacute rhinitis, urticaria, neurodermatitis |
| [ | Measure effects of positive and negative ions on hay fever symptoms | N.S. | Patients male and female aged 4 to 59 | 123 | Relief from hay fever and asthma |
| [ | Measure physiological and subject effects of breathing ionized air. | N.S. | 60 subjects, 25 F and 35 M, aged 10–68 yrs. 45 were normal, 15 had arthritis, 1 had pulmonary tuberculosis, 1 had hypertension, 2 with extreme nervousness, 1 with anemia, and 2 with undernutrition. | 60 | Pulse rate, blood pressure, respiration rate, mouth temperature, metabolism (oxygen consumption), arterial and finger blood, subjective sensation, subjective impression |
| [ | Measure therapeutic effects of negative ions on asthmatics | Double-blind | Chronic asthma patients from hospital aged 15–53 yrs | 16 | Severity (scored from mild, moderate, or severe) of wheezing, dyspnea, coughing, and septum, and side effects in nose and throat |
| [ | Measure pulmonary effects of negative and positive ions. | Subject-blind | Patients (7 F & 8 M) aged 16 to 48 yrs with bronchial asthma who were hospitalized for an extended allergy testing. | 15 | Lung function (FEV1), histamine threshold for 25% reduction in FEV1, and subjective scoring (air quality, breathing comfort, temperature). |
| | | | | | |
| [ | Measure physiological effects of negative and positive ions. | Subject-blind | Experiment 1: Six healthy women (age range: 20 to 30 years) chosen at random and Experiment 2: 5 women and 7 men (age range: 19 to 45 years) selected from 125 subjects because they appeared to be most sensitive to ionization | Experiment 1: 6 women Experiment 2: 5 women and 7 men | Experiment 1: skin temperature, rectal temperature, comfort temperature, pulse rate, respiratory rate, mental performance, and subjective feelings of comfort Experiment 2: same as in Experiment 1 except for comfort temperature |
| [ | Measure pulmonary, biochemical, emotional, and physical symptom effects of positive and negative ions on asthma. | Double-blind controlled | Asthmatic patients aged 35–64 (8 female and 1 male). | 9 | Pulmonary (FEV1), pulse and blood pressure, serum theophylline, urinary serotonin metabolite (5HIAA), symptom, response to three questionnaires designed to elicit somatic response and mood changes (Sharav #1 and 2, Adjective check) |
| [ | Measure perception of environment, personal comfort, and physical symptom effects of negative ions on workers in a "sick-building" office setting | Subject-blind | Workers in five rooms of office building | 26 | Linear analogue scores on environment and personal comfort; physical symptom. |
| [ | Measure effects on physiological parameter and subjective state from exposure to positive and negative ions. | Subject-blind | Male medical student paid volunteers aged 18–25 yrs; "morning" group N = 6 and "afternoon" group N = 5 to represent different metabolic states during the day. | 11 | Basal or total metabolism/oxygen consumption (depending on morning or afternoon group), blood pressure, pulse rate, respiratory rate, oral temperature, urine volume, and self-reported subjective state. |
| [ | Measure effects of negative ion on physiological parameters and circadian rhythm at rest and during exercise. | Subject-blind cross-over | Male aged 19–25 yrs experienced in physical training and without respiratory ailments. | 8 | Rectal temperature, heart rate, oxygen uptake (VO2) and minute ventilation (VE), state anxiety per Spielberger (1970), and perception of effort per Borg (1970). |
| [ | Measure effects of weather-related positive ions on pulmonary functions of asthmatics | N.S. | 6 F and 6 M aged 41–69 yrs recruited from advertisement for subjects with weather-related asthmatic condition | 12 | Mean peak flow at four times a day measured by subjects using Mini Wright Peak Flow Meter |
| [ | Measure physiologic effects and subjective impressions after exposure to light positive and negative air ions. | Subject- blind | 17 M and 8 F, aged 22–51 yrs recruited from University research students, lab technicians, and faculty members. Secondary experiments among arthritic patients and infants. | 25 | Physiological observations such as, heart rate, blood pressure, metabolic rate, respiration; subjective sensations |
| | | | |||
| [ | Measure adverse effect of positive air ions and beneficial effect of negative air ions on respiratory allergies. | Double-blind randomized | "Reversible" condition (e.g., hay fever), "partially-reversible" condition (e.g., asthma), and "Irreversible" condition (e.g., pulmonary emphysema) patients; N = 12, 10, and 4, respectively. | 26 | Six pulmonary functions (VC, total VC1, total VC3, MEFR, MBCR, SBT) |
| [ | Measure effects of positive and negative ions on asthmatic, bronchitis, and hay fever patients | N.S. | Patients with mild to moderate asthma, mild bronchitis, or hay fever | 24 | Lung function (FVC, FEV1, and MMFR) |
| [ | Measure pulmonary effects of negative and positive ions. | Not blinded nor randomized | Subjects with severe emphysema/chronic pulmonary disease and/or fibrosis | 46; 26; 79 | VC, FEV0.5, FEV1, FEV3, MBC, MPFR |
| [ | Measure efficacy of negative ion treatment for asthma patients. | Double-blind crossover | Men and women with asthma; 1/20 subject dropped out. | 20 | Peak expiratory flow rate (PEFR); self-reported symptoms; self medication. |
| [ | Measure whether the body is a collector of air ions and biological effects of air ions. | N.S. | 77 individuals (half had cardiovascular disease. Various experiments conducted | 77 | Body as ion collector experiment: electrical current developed between body and ionizer; biological effects study: clinical symptoms (headache, nasal obstruction, husky voice, sore throat, itchy nose, dizziness, congested throat), maximum breathing capacity, and feeling of exhilaration. |
N.S.-not specified, FEV-forced expiratory volume, VC-vital capacity, PEFR-peak expiratory flow rate, MBC-Maximum breathing capacity, MPFR-Maximum peak flow rate, MMFR-maximum midexpiratory flow rate; 5HIAA-5-hydroxyindole acetic acid.
Experimental design and respiratory outcomes
| | | | |
| [ | Negative or positive | Calibrated to deliver 1 × 104 ions on 1 cm2 area 10 cm away; negative or positive ions. | Negative ion exposure - severity of bronchospasm decreased from 3 to 0.3 after negative ion exposure. Average of 7.5 hrs between start of exposure and effects. Respiratory rate decreased on average 27% after first exposure period. Severity of bronchospasm returned in 7/16 subjects who were followed with cessation of ion exposure; increase in respiratory rate returned in 6/10 subjects who were followed. Positive ion exposure - severity of bronchospasm increased from about 0 to average of 2 after positive ion exposure. Respiratory rate (measured in only 2 subjects) increased on average 20-25% after 3 hrs. Response to positive ion exposure "disappeared spontaneously" after 10 to 50 hrs despite continued exposure. Positive and negative ion exposures - effects are lost when ion concentrations were reduced by a factor of 10 to 20. Control group (at different hospital) - bronchospasm decreased from N.S. to 0 or increased from 0 to 1 after 6 to 7 days of conventional asthma treatment. |
| [ | Negative | 5 × 105 - 10 × 105 ion/cm3; negative; 4 × 105 - 5 × 105 ion/cm3; negative | Pre-exercise mean FEV1 before ion exposure 1.36 L/min (SEM 0.07) and after ion exposure 1.35 L/min (SEM 0.08) not significantly different. After exercise challenge mean delta FEV1: Controls 29% of baseline (SE 5%), Exposed 21% (SE 3%) was significantly different (t-test, p<0.015). Histamine challenged mean delta FEV1 before ion exposure was 70% (SE 6%) and after ion exposure was 69% (SE 5%) not significantly different; median provocative dose of histamine was higher with ion exposure than control but difference was not significant, and some patients became more and some less sensitive to histamine challenge after ion exposure. |
| [ | Negative | Concentration N.S.; negative | No significant difference in lung function when comparing exposed vs unexposed groups (unpaired t-test) or prior to exposure vs post-exposure for the exposed group (paired t-test). |
| [ | Positive | 5 × 105 - 10 × 105 ion/cm3; positive | Mean delta FEV1 = 35.3% (SEM 5%) with positive ion exposure; 24.7% (SEM 5.3%) control; the difference was significant (paired t-test, p<0.04); other parameters showed no significant change. |
| [ | Not specified | N.S. | Difference between active ionizer vs placebo ionizer was significant for airborne allergen concentration (reduction during active ionizer; p<0.0001 Mann–Whitney U-test; p<0.01 Chi-Square test), but non-significant for PEFR, symptom scores, and medication scores. Authors noted increased nighttime cough but difference did not reach a standard significance (p=0.055). |
| | | ||
| [ | Negative | Concentration N.S.; negative | Individual results - Four patient's mean morning PEFR during treatment period significantly improved when comparing to control period (Mann–Whitney U-test; p<0.05). Three patient's mean evening PEFR during treatment period significantly improved when comparing to control period (p<0.01). Three patient's mean morning and evening PEFR significantly decreased when in transition from exposure to control period (p<0.001). Two patients reported subjective improvement during exposure period. Group results - Lung function measurements (from self- and investigator-administered) & diary card scored by investigator showed no significant difference during exposure and control periods (two-way analysis; p>0.4). Lung function measurements (from self- and investigator-administered) alone scored by independent physicians showed no significant difference during exposure and control periods (p>0.7). |
| [ | Negative | Concentration N.S.; negative | Hay fever patients (n=17) = 35.3% relief, 47.06% complete relief, 17.64% no relief. All patients (n=27) = 29.63% relief, 33.33% complete relief, 37.04 no relief. |
| [ | Negative or positive | Negative 1,200 to 2,600 ion/cm3; Positive 2,000-6,500 ion/cm3. | Negative ion exposure (n=54) = 62.9% relief; positive ion exposure (n= 5) = 0% relief; control (n = 15) = 6.6% relief. Asymptomatic of hay fever prior to exposure but developed symptoms during exposure: negative ion = 0/37; positive ion = 6/10; control = 1/2. |
| [ | Negative or positive | 1-50% of generated 5,000-1,500,000 ion/cm3; positive or negative | Effects of ion exposure similar regardless of polarity or ion concentration. Tabular summary of averages of measured parameters with ion exposure during basal, 2–4 hrs after breakfast, and 3–5 hrs after lunch. Positive ion exposure resulted in a group of individuals reporting subjective sensation of dryness and irritation of the nose and throat, and frontal headache. Negative ion exposure led to relaxation, and decrease in physiological parameters. Freshness of air felt during negative ion exposure but preference was not strong enough to be significant. |
| [ | Negative or positive | N.S. (rate of 1 × 10-10 amp); negative and positive | 35/40 experiments saw no effects, and 5/40 experiments with negative or positive ion exposure saw mild to moderate wheezing and dyspnea. |
| [ | Negative or positive | ~30,000 ion/cm3; negative or positive. | Group 1 - significant differences in FEV1 over the 4 ion and no ion exposures (Friedman's test, p<0.04). Individual FEV1 higher during both negative (20/27 values) and positive (21/27 values) ion exposure intervals. No significant difference (Friedman's test) in subjective scoring of temperature (p=0.2), air quality (p=0.3), and breathing comfort (p=0.7). Group 2 - no significant difference in histamine threshold after exposure to either ion exposures (Friedman's test, p<0.4) and no change was "demonstrated" (Wilcoxon match pair) in FEV1 from no ion to either positive or negative ion exposure. |
| | | | |
| [ | Negative or positive | 300 – 9,000 ions/cm3 | No significant effects of ionization were observed in either experiment except in certain partial means for the mental performances in Experiment II. |
| [ | Negative or positive | 60,000 - 110,000 ion/cm3; negative or positive | Mean FEV1 and pulse not significantly different between positive and negative ion exposure or from baseline (paired two-tail t-test); blood pressure significantly higher with negative ion exposure (p <0.01; paired two-tail t-test) and after 2 hours of positive ion exposure (p <0.05; paired two-tail t-test); no significant difference between positive and negative ion exposure in serum theophylline, urinary 5HIAA, or in questionnaire results. |
| [ | Negative | 1841 ion/cm3; negative | No significant effects observed, except for slightly more complaints of upper respiratory tract infection and nausea that may have been attributable to mild flu-like disorder in this study population. |
| [ | Negative or positive | 5 × 106 - 6 × 106 ion/cm3; positive or negative | Results for group-level data: basal or total metabolism/oxygen consumption, systolic and diastolic blood pressure = no significant difference between positive, negative, and control exposures. Self-reported subjective state - if 13 comment types are grouped as undesirable or desirable state, "slight difference" (higher) in frequency of reported undesirable state during positive ion than negative ion or control exposures (no statistical comparison shown). |
| [ | Negative | 172,000 ion/cm3; negative ions | With negative ion exposure and at rest, core (rectal) temperature, heart rate, VO2, and VE averaged over four times during the day is reduced significantly in comparison to neutral (no ion exposure) condition (three-way ANOVA, p<0.05). At both 90W and 180W exercise trials, rectal temperatures during the day with negative ion exposure averaged over four times were significantly different from no ion exposure (three-way ANOVA, p<0.05); differences between exposure and no exposure in heart rate (absolute or difference from rest) were insignificant; differences in absolute VO2 and VE between exposure and no exposure were insignificant; differences in the change from rest in VO2 and VE were significant (three-way ANOVA, p<0.05). Differences between exposure and no exposure in the modeled circadian rhythm acrophase amplitude of rectal temperature was significantly during rest (t-test, p<0.05) but not during both exercises. Differences between exposure and no exposure in the modeled circadian rhythm for VO2 and VE were not significant. Differences between exposure and no exposure in perceived exertion during exercise were not significant. |
| [ | Negative or positive | Positive and negative ions were measured. Positive ion peak concentration defined as >=2,000 ion/. | Difference between mean peak flow prior to weather fronts and during peak positive ion concentration versus same times during normal days were non-significant (paired t-test). |
| [ | Negative or positive | 100,000 ion/cm3; negative, positive, or placebo | No significant pulmonary function differences comparing treatments and clinical conditions. Data on grading presented in Figure |
| [ | Negative or positive | 125,000 or greater ion/cm3; positive and negative | Mean and S.D. of % change in FVC, FEV1, and MMFR with positive, negative, or control exposure tabulated for each comparison. No significant changes or differences with positive, negative, or no ionization. |
| [ | Negative or positive | 500,000 ion/cm3 | 1 hour exposure: no significant change with negative ion exposure, 9 subjects; 3 hour exposure: ventilation Factor = 52.2% (S.D. 4.3%) with negative ion exposure; subjectively, 10/33 felt better, 1 worse, and 22 no effect. No correlation between subjective improvement and pulmonary function measurements, 22 subjects; 2 week exposure: ventilation Factor =41.8% (S.D. 5%) with negative ion exposure; subjectively, 10/33 felt better, 1 worse, and 22 no effect. No correlation between subjective improvement and pulmonary function measurements, 15 subjects. |
| [ | Negative | ±150,000 ion/cm3; measured monthly. Group 1 mean = 203,000 ion/cm3; Group 2 mean = 183,000 ion/cm3. | No significant differences in PEFR, symptom scores, and medication scores were found between active ionizer vs placebo or no ionizer use (paired t-test). |
| [ | Negative or positive | Body as ion collector experiment: 32,000 positive ion/cm3 or 80% of 32,000 (approx 26,000) negative ions/cm3; biological effects study 32,000 ion/ positive or negative. | Biological effects study: Study I-16 with positive ion exposure had symptoms; Study II- 4/13 with negative ion exposures had symptoms; Study III- 2/7 during negative ion exposure and 7/7 during positive ion exposure; Study IV- 3/20 with symptoms during second no ion period, 17/20 with symptoms during positive ion exposure, and 6/20 with persistent symptoms during last no ion exposure period; Study V-1/21 with symptoms during no ion exposure and 5/21 during placebo ion exposure; Maximum breathing capacity study-reduced from 35 L/min to 25 L/min after positive ion exposure, no reduction after negative ion exposure; Effects of grounding study-5/11 developed symptoms with positive ion exposure and grounding, 9/11 developed symptoms with positive ion exposure and no grounding; Temperature and humidity study-no difference in symptoms, during low humidity the symptoms were more frequent and more severe than comparison. |
N.A. - not applicable; N.S. - not specified. Forced expiratory volume - FEV; forced vital capacity-FVC; peak expiratory flow rate-PEFR; standard error of mean-SEM; standard deviation-S.D.; 5-hydroxyindole acetic acid-5HIAA; oxygen consumption-VO2; minute volume-VE.
Figure 1Difference in group means for PEFR (L/min) testing after exposure to negative air ions.
Reported overall study conclusions for air ions and pulmonary and ventilatory measures
| [ | | | “It is concluded that we have not shown any effect of highly ionized air upon these ventilator tests.” | |
| [ | | | “It is concluded that negative ionization of inspired air can modulate the bronchial response to exercise but the effect on the response to histamine is much more variable.” [Note: no effect seen in non-exercise challenge] | |
| [ | | | “It is concluded that positive ionization aggravates the bronchial response to exercise.” [Note: only significant difference was for post-exercise FEV comparisons] | |
| [ | | | “…exposure to positive or negative small air ions did not influence the clinical condition…findings do not support a significant role of small air ions in exacerbation or treatment of bronchial asthma.” | |
| [ | | | “A slight but significant (at the 5% level) improvement in the lung function was demonstrated during positive as well as negative ion exposure…” | |
| [ | | | “A slight but significant (at 5% level) improvement in the lung function was demonstrated in nine patients during positive as well as negative ion exposure…” | |
| [ | | | “No significant changes were observed in the lung volume measurements…after breathing the negative ions.” [Note: no effect for short or long exposure] “To date our work has failed to demonstrate any significant objective changes which can be measured from breathing of negative or positive ions either favorable or unfavorable.” | |
| [ | | | “There were no significant differences in PEFR…between the periods that active ionizers and either no ionizers or placebo ionizers were in operation…study has failed to show a statistically significant benefit in asthmatic subjects from the use of negative ion generators.” | |
| [ | | | “…it is unlikely that exposure to negative ions will be of significant benefit in the majority of patients with asthma…the effects of negatively ionized air on such patients remains to be determined.” | |
| [ | | | “…failed to show any significant effects when judged by subjective clinical appraisal or evaluated by objective pulmonary function…ionization should not be recommended as a therapeutic adjuvant in the treatment of these diseases.” | |
| [ | | | “The mean peak flow rates in this group of patients did not vary significantly with the changes in ion levels or other meteorologic factors which resulted from the passage of these weather fronts.” | |
| [ | | | “This study indicates that the use of ionizers cannot be recommended in the homes of asthmatic subjects to improve their symptoms.” | |
| [ | | | “No significant changes were found in…exposures of between one and two hours to either positive or negative ions, compared to changes which occurred in control experiments.” “As in our previous work, nothing definite was found to justify the use of artificial ionization in ventilation or air conditioning.” [Note: upper respiratory irritation increased after exposure to positive ions, based on subjective responses but may be due to weather effects.] | |
| [ | | | “…positive ions produce irritation of the respiratory tract especially when the humidity is low, the patient is grounded and high ion densities are employed.” [Note: primarily based on subjective symptom responses, not objective clinical measurements.] | |
| [ | | | “…under the conditions of the present experiments nothing definite was found to justify the use of artificial ionization in general ventilation.” | |
| [ | | | “They [the experiments] certainly do tend to justify the opinion that, so far as normal subjects are concerned, such effects are unproven and improbable.” | |
| [ | | | “It was demonstrated that atmospheric ions have an effect on infants, especially those suffering from asthmatic (spastic) bronchitis.” [Note: in some subjects, negative ions had a beneficial impact on bronchial spasms and respiration rate, and positive ions had a deleterious impact in spastic attacks in some normal infants.] | |
| [ | | | “We concluded that nocturnal administration of negative air ionization has no significant effect upon lung function in the asthmatic child using the above tests.” | |
| [ | | | “…negative air ions significantly reduced resting values of all physiological variables…these effects tended to disappear under exercise conditions.” | |
| [ | | | “…no difference in the biologic effect of positive and of negative atmospheric ions…the negative (like the positive) ions did not appear to influence the patient’s typical pattern of wheezing and remission.” | |
| [ | | | “…twenty-seven patients were exposed to the influence of negative ionization in an experimental room. Many patients with hay fever and asthma responded favorably to the physical alteration of the environment.” | |
| [ | | | “Favorable responses were elicited by the negative polarity. Positive ionization caused either no relief or increased distress.” | |
| [ | “Negative ion generators are not to be recommended for this problem [sick building syndrome], especially as the data on temperature and humidity provided a good 'internal control' that real effects were being measured.” | |||
*not stated explicitly-presumed negative.